Interestingly, as opposite to what was observed in leukemia cells, HDAC and sirtuin inhibitors were poorly active and failed to show any cooperation in CD34+ hematopoietic progenitors and in PBMCs. The gene discussed is HDAC9; the disease is leukemia.